Common Cold
📧 Sign up to get email alerts when something new happens for Common Cold.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: Efficacy and Safety of Susu Zhike Granules for Treating Acute Cough Due to Common Cold With Cold-cough Syndrome in Children [Phase 2]
Completed Phase 2 trial assessing the efficacy and safety of Susu Zhike Granules for acute cough due to the common cold with cold-cough synd…
-
CLINICAL_TRIALS trial_result · 2024-08-23Clinical Trial Update: Evaluation of ColdZyme® Mouth Spray on Prevention and Alleviation of Rhinovirus Induced Common Cold [NA]
Clinical trial evaluating ColdZyme Mouth Spray for prevention and relief of rhinovirus-induced common cold; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Effectiveness of Antrodia Cinnamomea Mycelia on Improving Immune Response in Subhealth People [NA]
A completed clinical trial evaluated whether Antrodia cinnamomea mycelia can improve immune response in subhealth individuals, including tho…
-
CLINICAL_TRIALS research · 2024-08-02Clinical Trial Update: Efficacy of Two Nasal Products Based on Diluted Seawater in the Treatment of Upper Respiratory Infections/Conditions [NA]
A clinical trial entry describing the evaluation of two nasal products based on diluted seawater for upper respiratory conditions, currently…
-
CLINICAL_TRIALS research · 2024-08-02Clinical Trial Update: Efficacy and Safety in the Combination of Ibuprofen / Loratadine Versus Ibuprofen Versus Loratadine [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of combining ibuprofen with loratadine versus ibuprofen alone and loratadine alone for th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-07-18Clinical Trial Update: Thermotherapy in Acute Nonspecific Neck Pain [NA]
A clinical trial update shows that thermotherapy for acute nonspecific neck pain is currently recruiting.
-
CLINICAL_TRIALS withdrawal · 2024-07-05Clinical Trial Update: Clinical Trial to Optimise Levels of Vitamin D for Rhinovirus Protection [Phase 2]
A Phase 2 clinical trial evaluating whether optimizing vitamin D levels can protect against rhinovirus-induced common cold was withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: Otrivine: Quality of Life (QoL) Impact in a Real-World Setting [Phase 4]
Phase 4 real-world study evaluating QoL impact of Otrivine (xylometazoline) for the common cold; results posted May 17, 2024.
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Beetroot Juice NO Cold Study [Phase 2]
Phase 2 clinical trial evaluating beetroot juice for reducing cold symptoms and impact on exhaled nitric oxide in individuals with respirato…
-
FDA approval · 2024-05-14FDA Approved: ALLERGY RELIEF-D — Original Application (HEB)
FDA approves ALLERGY RELIEF-D, a combination product of loratadine and pseudoephedrine sulfate, under an original application by HEB, for re…
-
CLINICAL_TRIALS trial_result · 2024-04-01Clinical Trial Update: Efficacy and Safety of Ingavirin®, Capsules, 60 mg, in Children With Influenza and Other Acute Respiratory Viral Infections [Phase 4]
Phase 4 trial update assessing efficacy and safety of Ingavirin 60 mg capsules in children with influenza and other acute respiratory viral …
-
FDA approval · 2024-03-20FDA Approved: DIPHENHYDRAMINE HYDROCHLORIDE — Original Application (Sagent Pharmaceuticals)
FDA approved a generic diphenhydramine hydrochloride product through an Original Application (ANDA 218448) by Sagent Pharmaceuticals.
-
FDA approval · 2023-12-15FDA Approved: TUXARIN — Supplemental Application (Mainpointe Pharmaceuticals)
FDA approved a supplemental application for TUXARIN (codeine phosphate and chlorpheniramine maleate) submitted by Mainpointe Pharmaceuticals…
-
FDA approval · 2023-11-09FDA Approved: CLARITIN-D 12 HOUR — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for Claritin-D 12 Hour (loratadine and pseudoephedrine sulfate) from Bayer HealthCare LLC. This acti…
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: Active and Placebo Controlled Study to Test the Efficacy and Safety of an Aspirin-Lidocaine Lozenge in the Symptomatic Treatment of Sore Throat Associated With a Common Cold [Phase 3]
A phase 3 randomized controlled trial evaluating an aspirin-lidocaine lozenge for symptomatic treatment of sore throat in common cold; study…
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral Infections [Phase 3]
Phase 3 trial update evaluating the efficacy and safety of Ingavirin syrup (30 mg/5 ml) in children with influenza and acute respiratory vir…
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of XC8 40 mg film-coated tablets for dry non-productive cough associated with acute respi…
-
FDA approval · 2023-05-08FDA Approved: BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for the cough/cold combination of brompheniramine maleate, pseudoephedrine hydrochloride, and dextro…
-
FDA approval · 2023-02-28FDA Approved: PHENYLEPHRINE HYDROCHLORIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a generic version of phenylephrine hydrochloride through an Original Application (ANDA 209968) by Heritage Pharmaceuticals (d/b…
-
CLINICAL_TRIALS trial_result · 2022-12-07Clinical Trial Update: The Preventive Effectiveness of the Individualized Jade Wind-Barrier Herbal Tea Bag on the Common Cold in Elderly With Qi-deficiency Constitution (CCJWBT): A Pragmatic Randomized Controlled Trial [Phase 2]
Phase 2 pragmatic randomized trial evaluating an individualized Jade Wind-Barrier herbal tea bag for preventive effectiveness against the co…
-
FDA approval · 2022-10-27FDA Approved: BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE — Supplemental Application (Acella Pharmaceuticals, LLC)
The FDA granted supplemental approval for Acella Pharmaceuticals' generic combination product containing brompheniramine maleate, pseudoephe…
-
FDA approval · 2022-09-29FDA Approved: PHENYLEPHRINE HYDROCHLORIDE — Original Application (NorthStar RxLLC)
FDA approved phenylephrine hydrochloride under an original application for temporary relief of nasal congestion due to the common cold, hay …
-
FDA approval · 2022-08-30FDA Approved: PHENYLEPHRINE HYDROCHLORIDE — Original Application (Lifestar Pharma LLC)
FDA approves Lifestar Pharma LLC's phenylephrine hydrochloride under an Original Application (ANDA). This approval introduces a generic phen…
-
FDA approval · 2022-08-22FDA Approved: GUAIFENESIN AND PSEUDOEPHEDRINE HCL — Original Application (Granules India Ltd)
FDA approved Granules India Ltd's guaifenesin and pseudoephedrine HCl as an Original Application (ANDA) for a generic combination product.
-
FDA approval · 2022-06-01FDA Approved: NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE COLD AND SINUS — Original Application (VESPYR BRANDS LLC)
FDA approved Naproxen Sodium and Pseudoephedrine Hydrochloride Cold and Sinus as an Original Application for a new combination OTC product t…